ARCHIVES

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

This article is from The Cancer Letter archive.

Vol. 40 No. 25 | June 20, 2014

Download PDF Visit The Full Archive

Related Articles

ASCO: NCI Director Should Be A Clinician; NBCC Endorses Mary-Claire King

March 10, 1995

NTP Board Okays Contract Concepts

July 10, 1981

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

October 6, 1995

UPCI Recruits Shin To Lead Head & Neck Cancer Program.

April 27, 2001

Adjuvant Nutrition Breast Cancer Study Offered To Groups

March 19, 1982

Coffee, Soft Drinks Have Little Association With Colon Cancer

May 28, 2010